Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/1999
03/03/1999EP0898596A1 Squarate dyes and their use in fluorescent sequencing method
03/03/1999EP0898576A1 Death domain containing receptors
03/03/1999EP0898575A2 A combinatorial protecting group strategy for multifunctional molecules
03/03/1999EP0820462B1 Hydrolysis and photocleavage of nucleic acid using a metal complex
03/03/1999EP0797683A4 Methods and apparatus for dna sequencing and dna identification
03/03/1999EP0733126A4 Immobilized mismatch binding protein for detection or purification of mutations or polymorphisms
03/03/1999EP0673420B1 Mammalian receptors for interleukin-10 (il-10)
03/03/1999EP0558732B1 Production of chromosome region specific dna sequences and transamination
03/02/1999US5877309 Nucleotide sequences which suppress expression of jun n-terminal kinase oncogene by complementary hybridization; antiproliferative agents, antitumor agents, anticarcinogenic agentsand antimetastasis agents
03/02/1999US5877305 DNA encoding biosynthetic binding protein for cancer marker
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877290 Humanized antibody fragment that binds a polypeptide sequence encoded by cdna of an anti-hypercalcemic hormone; treatment of electrolyte disorders, kidney failure, bone and heart disorders, osteoporosis, paget's disease
03/02/1999US5877279 Materials for the production of nanometer structures and use thereof
03/02/1999US5877179 Cystic fibrosis
03/02/1999US5877160 Compositions and methods of treatment of androgen-associated baldness using antisense oligomers
03/02/1999US5877021 Induction of graft tolerance, treatment of autoimmune diseases, inflammatory disorders and allergies in particular, by inhibition of b7-1, b7-2, b7-3 and cd40.
03/02/1999US5877017 Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999US5877001 Polynucleotide encoding thermostable enzyme isolated from thermococcus; for removal of l-arginine, l-phenylalanine, or l-methionine from n-terminal of peptides in peptide synthesis reactions when ester functionality is present
03/02/1999US5876971 Amino acid sequence of protein isolated from insects which suck the blood of mammals; anticoagulants; treatment of thromboses or unstable angina or arteriosclerosis; prevention of reblockage of vessels after angioplasty
03/02/1999US5876969 Fusion polypeptide of therapeutic polypeptides attatched to c-and n-terminals of human serum albumin; for high plasma stability, minimization of dosage, side effect reduction
03/02/1999US5876966 Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production
03/02/1999US5876945 Immunoassay using reporter linked antibody against processed d1 polypeptide important in photosynthesis to detect enzymatic activity; low signal is indicator of enzyme inhibitor
03/02/1999US5876938 Use of boron-containing polynucleotides as diagnostic agents
03/02/1999US5876931 Identification of genes
03/02/1999US5876930 Detecting polynucleotide in sample using oligonucleotide probe containing fluorescence and quencher molecules; probe has different conformations allowing different signal intensities when hybridized or unhybridized
03/02/1999US5876929 Analysis kit identifying dna, distinguishes between different eukaryotic sources; enzyme digest of driver dna and tester dna with target dna, ligate adaptors, amplify, melt, anneal of amplicons, use as probes to screen cells
03/02/1999US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
03/02/1999US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors
02/1999
02/25/1999WO1999009214A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
02/25/1999WO1999009203A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes
02/25/1999WO1999009049A1 Hypoxia-regulated genes
02/25/1999WO1999009046A1 Hypoxia-regulated genes
02/25/1999WO1999009045A1 Antisense and antigene therapeutics with improved binding properties and methods for their use
02/25/1999WO1999009044A1 Ribonucleoside-derivative and method for preparing the same
02/25/1999WO1999009042A2 Microstructures for the manipulation of fluid samples
02/25/1999WO1999009041A2 Solution phase synthesis of oligonucleotides
02/25/1999WO1998054344A3 Modulators of morphogen expression and methods of identifying the same
02/25/1999WO1998053101A3 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases
02/25/1999WO1998033808A3 A reversible stoichiometric process for conjugating biomolecules
02/25/1999DE19736366A1 Isolating anionic substances e.g. protein, nucleic acids, from aqueous systems
02/25/1999CA2720384A1 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
02/25/1999CA2301309A1 Microstructures for the manipulation of fluid samples
02/25/1999CA2301139A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
02/25/1999CA2300938A1 Antisense and antigene therapeutics with improved binding properties and methods for their use
02/25/1999CA2300874A1 Solution phase synthesis of oligonucleotides
02/25/1999CA2298630A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes
02/24/1999EP0897991A2 Small Triplex Forming PNA Oligos
02/24/1999EP0897989A2 Vehicle for delivery of particles to a sample
02/24/1999EP0897983A2 Antibody against CD40-L
02/24/1999EP0897426A1 Matrix metalloprotease
02/24/1999EP0897390A1 Human tumor necrosis factor delta and epsilon
02/24/1999EP0815114A4 Nucleic acid synthesis using photoremovable protecting groups
02/24/1999EP0789707A4 Amino acid nucleic acids
02/24/1999EP0775149A4 Novel protecting groups and use thereof in an improved process for oligonucleotide synthesis
02/24/1999EP0700440B1 Regulator of contact-mediated hemolysin
02/24/1999EP0449968B1 Process for the preparation of human dnase
02/24/1999CN1208730A Prodn. of human growth hormone by using animal mamma as raw material
02/23/1999US5874568 Coupling unit of (6-4) photoproduct, process for preparing the same, process for preparing oligonucleotide containing (6-4) photoproduct by using the same and process for preparing DNA containing (6-4) photoproduct by using the same
02/23/1999US5874557 Enzyme inhibitors which bind to polymerases at ambient temperatures and prevent amplification of nontarget oligonucleotides during polymerase chain reactions; for accurate diagnosis
02/23/1999US5874556 Hybrid genes for use in the production of TH -independent cytotoxic T cells
02/23/1999US5874554 Dispensing a mixture of acetonitrile with a stabilizing co-solvent which is an organic solvent having a boiling point or flash point greater than about 100.degree. c., and is miscible with acetonitrile
02/23/1999US5874553 Phosphonomonoester nucleic acids, process for their preparation, and their use
02/23/1999US5874552 For solid state oligonucleotide synthesis
02/23/1999US5874544 Antibodies to APO(A)
02/23/1999US5874542 Single chain antibodies specific to VEGF receptors
02/23/1999US5874534 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
02/23/1999US5874533 HIV-2 envelope polypeptides
02/23/1999US5874532 Method for solution phase synthesis of oligonucleotides and peptides
02/23/1999US5874527 Plasmodium vivax blood stage antigens
02/23/1999US5874526 Toxoplasma gondii antigens
02/23/1999US5874416 Antitumor
02/23/1999US5874399 Progenitor B cell stimulating factor
02/23/1999US5874267 Expression of surface layer proteins
02/23/1999US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3
02/23/1999US5874245 Human G-protein coupled receptor (HIBCD07)
02/23/1999US5874218 Method for detecting a target compound in a substance using a nucleic acid ligand
02/23/1999US5874209 Regulation of transcription factor, NF-IL6/LAP
02/23/1999US5874083 Proteins and complexes for immune response
02/19/1999CA2245310A1 Sca7 gene and methods of use
02/18/1999WO1999007899A1 Denaturing multi ion polynucleotide chromatography for detecting mutations
02/18/1999WO1999007749A1 Complex chemical compound, synthesis and various applications of said compound
02/18/1999WO1999007405A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF αvβ6
02/18/1999WO1999007383A1 Composition and method for regulating cell proliferation and cell death
02/18/1999WO1998045473A3 Dna probes for campylobacter, arcobacter and helicobacter
02/18/1999CA2299605A1 90 human secreted proteins
02/18/1999CA2299555A1 Complex chemical compound, synthesis and various applications of said compound
02/18/1999CA2298019A1 Denaturing multi ion polynucleotide chromatography for detecting mutations
02/18/1999CA2297736A1 Treatment of acute lung injury and fibrosis with antagonists of .alpha.v.beta.6
02/17/1999EP0897005A1 Polyester synthase and a gene coding for the same
02/17/1999CN1208078A Genes encoding branched-chain alpha-ketoacid dehydrogense complex from streptomyces Avermitilis
02/16/1999US5872244 3' protected nucleotides for enzyme catalyzed template-independent creation of phosphodiester bonds
02/16/1999US5872243 Caged nucleotides
02/16/1999US5872233 Mycoplasma arthritidis T-cell mitogen
02/16/1999US5872232 2'-O-modified oligonucleotides
02/16/1999US5872107 Anticarcinogenic agents capture therapy for tumors
02/16/1999US5872106 Antimessenger oligonucleotide against urokinase receptor
02/16/1999US5872105 Antiparallel binding domain
02/16/1999US5872003 DNA sequencing by mass spectrometry via exonuclease degradation
02/16/1999US5872000 Nitrilase gene